Aminolaevulinic acid (ALA)-induced photodynamic therapy in bladder cancer

Completed

• Conditions: Cancer (neoplasms): Bladder (superficial); Cancer; Bladder

• Registration Number: ISRCTN93651553
• Lead Sponsor: HS R&D Regional Programme Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-23
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 28

Inclusion Criteria

28 patients with carcinoma in situ and superficial invasive carcinoma of the bladder who have been advised to have cystectomy or TransUrethral Resection of Tumour (TURT) (respectively) will be invited to participate in the study and written informed consent obtained.

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Potential patient and health service benefits

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration